August 16, 2022

The August 2022 News from ECOG-ACRIN blog is now available

August 10, 2022

President Biden announces his intent to appoint Dr. Monica Bertagnolli as the next NCI director

August 9, 2022

Early-career investigators: Submit an abstract for the 2022 Young Investigator Symposium by Wednesday, 9/7

July 21, 2022

Group co-chairs Peter O’Dwyer and Mitch Schnall commend the selection of Monica Bertagnolli as the next NCI director

July 15, 2022

Ongoing Smoke Free Support Study 2.0 featured in BioMed Central’s Public Health Journal

July 14, 2022

Media Advisory: Blood publishes long-term outcomes of patients with CLL in the practice-changing E1912 trial

July 2, 2022

What is ECOG-ACRIN EA2142? And why should you care?

June 28, 2022

The Summer 2022 advocacy blog, Considering Clinical Trials, is now available

June 22, 2022

FDA approves dabrafenib plus trametinib for BRAF V600E-mutated tumors based on data from NCI-MATCH

ECOG-ACRIN Cancer Research Group